T
Tanuja N. Gengiah
Researcher at Centre for the AIDS Programme of Research in South Africa
Publications - Â 53
Citations - Â 5056
Tanuja N. Gengiah is an academic researcher from Centre for the AIDS Programme of Research in South Africa. The author has contributed to research in topics: Microbicides for sexually transmitted diseases & Medicine. The author has an hindex of 19, co-authored 46 publications receiving 4799 citations. Previous affiliations of Tanuja N. Gengiah include National Institutes of Health & University of Winchester.
Papers
More filters
Journal ArticleDOI
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim,Salim S. Abdool Karim,Salim S. Abdool Karim,Salim S. Abdool Karim,Janet A. Frohlich,Anneke Grobler,Cheryl Baxter,Leila E. Mansoor,Ayesha B. M. Kharsany,Sengeziwe Sibeko,Koleka Mlisana,Zaheen Omar,Tanuja N. Gengiah,Silvia Maarschalk,Natasha Arulappan,Mukelisiwe Mlotshwa,Lynn Morris,Douglas Taylor +17 more
TL;DR: Tenofovir in a vaginal gel formulation shows significant protection against HIV infection in a randomized control trial, and could potentially fill an important HIV prevention gap, especially for women unable to successfully negotiate mutual monogamy or condom use.
Journal ArticleDOI
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Salim S. Abdool Karim,Kogieleum Naidoo,Anneke Grobler,Nesri Padayatchi,Cheryl Baxter,Andy Gray,Tanuja N. Gengiah,Sheila Bamber,Aarthi Singh,M. Khan,Jacqueline Pienaar,Wafaa. El-Sadr,Gerald Friedland,Quarraisha Abdool Karim +13 more
TL;DR: The initiation of antiretroviral therapy during tuberculosis therapy significantly improved survival and provides further impetus for the integration of tuberculosis and HIV services.
Journal ArticleDOI
Integration of antiretroviral therapy with tuberculosis treatment
Salim S. Abdool Karim,Kogieleum Naidoo,Anna Christina. Grobler,Nesri Padayatchi,Cheryl Baxter,Andy Gray,Tanuja N. Gengiah,Santhanalakshmi Gengiah,Anushka Naidoo,Niraksha. Jithoo,Gonasagrie Nair,Wafaa. El-Sadr,Gerald Friedland,Quarraisha Abdool Karim +13 more
TL;DR: Deferral of the initiation of ART to the first 4 weeks of the continuation phase of tuberculosis therapy in those with higher CD4+ T-cell counts reduced the risks of IRIS and other adverse events related to ART without increasing the risk of AIDS or death.
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women: Supporting Online Material
Journal Article